Drug Shortage Report for SELEGILINE

Last updated on 2018-03-27 History
Report ID 17328
Drug Identification Number 02230641
Brand name APO-SELEGILINE
Common or Proper name SELEGILINE
Company Name AA PHARMA INC
Market Status MARKETED
Active Ingredient(s) SELEGILINE HYDROCHLORIDE
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code N04BD
ATC description DOPAMINERGIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-08-31
Actual start date 2017-08-07
Estimated end date 2018-03-30
Actual end date 2018-03-23
Shortage status Resolved
Updated date 2018-03-27
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1165 CREDITSTONE ROAD
VAUGHAN, ONTARIO
CANADA L4K 4N7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-07-26 English Compare
v2 2017-07-26 French Compare
v3 2017-08-08 English Compare
v4 2017-08-08 French Compare
v5 2017-11-20 English Compare
v6 2017-11-20 French Compare
v7 2018-02-09 English Compare
v8 2018-02-09 French Compare
v9 2018-03-27 English Compare
v10 2018-03-27 French Compare

Showing 1 to 10 of 10